Stock Earnings

Question 1

What are Tarsus Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Tarsus Pharmaceuticals Inc has a total asset of $376, Net loss of $-115

Question 2

What are the key financial ratios for TARS?

Accepted Answer

Tarsus Pharmaceuticals Inc's Current ratio is 2.47, has a Net margin is -63.18, sales per share of $4.83.

Question 3

How is Tarsus Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Tarsus Pharmaceuticals Inc largest revenue segment is Therapeutics, at a revenue of 182,953,000 in the most earnings release.For geography, United States is the primary market for Tarsus Pharmaceuticals Inc, at a revenue of 182,953,000.

Question 4

Is Tarsus Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, Tarsus Pharmaceuticals Inc has a net loss of $-115

Question 5

Does Tarsus Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Tarsus Pharmaceuticals Inc has liability of 152

Question 6

How many outstanding shares for Tarsus Pharmaceuticals Inc?

Accepted Answer

Tarsus Pharmaceuticals Inc has a total outstanding shares of 38.34

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	366	182	17	25	57	0
Revenue Growth (YoY)	184%	971%	-32%	-56%	--	--
Cost of Revenue	24	12	1	0	2	--
Gross Profit	341	170	15	24	54	--
Selling, General & Admin	365	237	108	44	25	8
Research & Development	63	53	50	42	41	18
Operating Expenses	428	290	159	87	67	27
Other Non Operating Income (Expenses)	0	0	0	0	0	--
Pretax Income	-81	-115	-135	-62	-13	-26
Income Tax Expense	--	0	0	0	0	0
Net Income	-81	-115	-135	-62	-13	-26
Net Income Growth	-40%	-15%	118%	377%	-50%	550%
Shares Outstanding (Diluted)	42.6	37.6	29.38	24.62	20.55	20.5
Shares Change (YoY)	11%	28%	19%	20%	0%	9%
EPS (Diluted)	-1.9	-3.07	-4.62	-2.52	-0.67	-1.31
EPS Growth	-46%	-34%	84%	276%	-49%	424%
Free Cash Flow	-62	-89	-122	-49	3	-21
Free Cash Flow Per Share	-1.45	-2.36	-4.15	-1.99	0.14	-1.02
Gross Margin	93.16%	93.4%	88.23%	96%	94.73%	--
Operating Margin	-23.77%	-65.93%	-841.17%	-248%	-21.05%	0%
Profit Margin	-22.13%	-63.18%	-794.11%	-248%	-22.8%	0%
Free Cash Flow Margin	-16.93%	-48.9%	-717.64%	-196%	5.26%	0%
EBITDA	-86	-119	-143	-62	-12	-27
EBITDA Margin	-23.49%	-65.38%	-841.17%	-248%	-21.05%	0%
D&A For EBITDA	1	1	0	0	0	0
EBIT	-87	-120	-143	-62	-12	-27
EBIT Margin	-23.77%	-65.93%	-841.17%	-248%	-21.05%	0%
Effective Tax Rate	--	0%	0%	0%	0%	0%

Tarsus Pharmaceuticals Inc (TARS) Price

TARS Stock Price Chart

TARS Income

Follow-Up Questions